Vaccination in multiple sclerosis: Tackling challenges and paving the way for effective immunization

René Carvajal1, Carmen Tur2, Blanca Borras-Bermejo3

  • 1Department of Neurology and Neuroimmunology, Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|March 12, 2025
PubMed
Summary

Optimizing vaccinations for patients with multiple sclerosis (PwMS) requires early immunization before disease-modifying therapies (DMTs) and tailored strategies to overcome challenges. Addressing vaccine hesitancy and ensuring inclusivity are key for effective immunization programs.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
44.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347